Notes: AZD 7624 is an inhibitor of p38α MAPK signaling.{72129} AZD 7624 (1 µM), in combination with the synthetic glucocorticoid dexamethasone (Item No. 11015), prevents LPS-induced increases in the levels of TNF-α and IL-6 secreted from primary human alveolar macrophages isolated from patients with chronic obstructive pulmonary disease (COPD).